Cancer-Causing Proteins Jacksonville NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Russell Earle Burgess, MD
(252) 635-3977
PO Box 68
Pollocksville, NC
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1974
Hospital
Hospital: Onslow Memorial Hospital, Jacksonville, Nc
Group Practice: Ecu Physicians Brody School Of Medicine

Data Provided by:
Bonnie J Goodwin
(252) 633-1010
137 Medical Lane
Pollocksville, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Bonnie Jeanne Goodwin, MD
(252) 633-1010
PO Box 68
Pollocksville, NC
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Female
Education
Medical School: Dartmouth Med, Hanover Nh 03755
Graduation Year: 1977
Hospital
Hospital: Craven Reg Med Authority, New Bern, Nc
Group Practice: Eastern Carolina Internal Medicine Pa

Data Provided by:
John Falletta
(919) 620-4467
2100 Erwin Rd
Durham, NC
Specialty
Hematology / Oncology

Data Provided by:
Anthony J Crimaldi
(704) 355-2272
1000 Blythe Blvd
Charlotte, NC
Specialty
Radiation Oncology

Data Provided by:
Gerard M McPhee
(252) 633-1010
137 Medical Lane
Pollocksville, NC
Specialty
Radiation Oncology

Data Provided by:
Russell E Burgess
(252) 633-1010
137 Medical Lane
Pollocksville, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Bonnie Goodwin
(252) 633-1010
PO Box 68
Pollocksville, NC
Specialty
Medical Oncology
Associated Hospitals
Eastern Carolina Internal Medicine Pa

David Allen Reardon, MD
(919) 668-1409
Room 3624 DUMC,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1986

Data Provided by:
Gerard M McPhee
(252) 633-1010
137 Medical Lane
Pollocksville, NC
Specialty
Radiation Oncology

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com